Background: The Hepatitis delta virus (HDV) is a defect RNA virus that requires the presence of the hepatitis B virus (HBV) for cellular infection. Worldwide, 350 million people are infected with HBV; 5% of these are superinfected with HDV. A chronic superinfection with HDV has a higher morbidity and mortality rate. It is clinically difficult to differentiate between an HBV and an HDV infection. Diagnosis is made via detection of HDV antibodies and HDV-RNA using PCR techniques. The only treatment option is peginterferon-alpha 180 μg subcutaneously once a week for 48 weeks.
Case Description: A 37-year-old man with a Syrian background and a chronic HBV infection presented with high levels of ALT indicating severe hepatitis. The level of detected HBV-DNA-particles was low, however, indicating that the HBV infection alone could not be responsible for the inflammation. Further investigations revealed a superinfection with HDV. The patient was successfully treated with peginterferon-alpha.
Conclusion: Severe hepatitis (high ALT level) in combination with a low HBV-DNA-particle level can indicate a HDV superinfection.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Incidence and outcome of hepatitis D virus infection in people with HIV in the era of tenofovir-containing antiretroviral therapy.
Clin Infect Dis
January 2025
Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.
Background: Tenofovir-containing antiretroviral therapy (ART) improves survival in HBV-coinfected people with HIV (PWH). We investigated the incidence of HDV infection and its clinical impact in HBV-coinfected PWH in the era of tenofovir-containing ART.
Methods: Between 2011 and 2022, HBV-coinfected PWH were included and followed until December 2023.
Prevalence, Risk Factors, and Clinical Profiles of Hepatitis D Virus in Nigeria: A Systematic Review, 2009-2024.
Viruses
October 2024
Department of Public Health, Universitas Padjadjaran, Bandung 40161, Indonesia.
Article Synopsis
- The World Health Organization advises hepatitis D virus (HDV) screening for those infected with hepatitis B virus (HBV), especially in resource-limited areas like Nigeria, due to HDV's serious health risks, including rapid liver disease progression.
- A systematic review using PRISMA guidelines analyzed 11 studies from 2009-2024, focusing on HDV prevalence, risk factors, and clinical outcomes in Nigeria, specifically looking at studies that employed IgG antibody testing or RNA diagnostics.
- The findings revealed HDV prevalence among HBV patients in Nigeria varied widely from 2.0% to 31.6%, with the highest rates in the Southwest among malaria patients, and a notable increase in prevalence among young males aged
Molecular Epidemiology of Hepatitis D Virus in the North-East Region of Romania.
Pathogens
September 2024
Department of Preventive Medicine and Interdisciplinarity Microbiology, Faculty of Medicine, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.
Article Synopsis
- The hepatitis D virus (HDV) causes severe liver damage, particularly in individuals already infected with chronic hepatitis B virus (HBV), making it a significant health concern.
- A study in Romania clinically characterized 82 patients with HDV and identified that all belonged to the HDV-1 genotype, revealing connections to groups in Italy, France, Spain, and parts of the Middle East.
- The findings emphasize the importance of understanding HDV epidemiology in Romania and suggest that migration patterns impact the distribution of the virus without affecting clinical outcomes among different patient clusters.
vHDvDB 2.0: Database and Group Comparison Server for Hepatitis Delta Virus.
Viruses
August 2024
Department of Microbiology and Immunology and Division of Microbiology, Graduate Institute of Biomedical Sciences, School of Medicine, Chang Gung University, Taoyuan 333, Taiwan.
The hepatitis delta virus (HDV) is a unique pathogen with significant global health implications, affecting individuals who are coinfected with the hepatitis B virus (HBV). HDV infection has profound clinical consequences, manifesting either as coinfection with HBV, resulting in acute hepatitis and potential liver failure, or as superinfection in chronic HBV cases, substantially increasing the risk of cirrhosis and hepatocellular carcinoma. Given the complex dynamics of HDV infection and the urgent need for advanced research tools, this article introduces vHDvDB 2.
View Article and Find Full Text PDFInterferon alpha induces a stronger antiviral effect than interferon lambda in HBV/HDV infected humanized mice.
Virus Res
November 2024
The Program for Experimental and Theoretical Modeling, Division of Hepatology, Department of Medicine, Stritch School of Medicine, Loyola University Chicago, Maywood, IL, USA.
Article Synopsis
- Recent studies show that pegylated interferon (IFN) treatments can significantly reduce hepatitis D virus (HDV) levels.
- The research involved testing the effectiveness of IFNλ and IFNα in humanized mice models, with some mice infected with both hepatitis B virus (HBV) and HDV, while others were infected with HDV after HBV.
- Results indicated that IFNα treatment resulted in a more substantial decrease in HBV and HDV levels compared to IFNλ, highlighting the need for further research on immune responses in treating these viruses.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!